Michal D.
- Country
- Czechia
- Department
- Neurologicka klinika
Research Overview
- Phase 3 Randomized Double-Blind Study of Orelabrutinib for Primary Progressive Multiple Sclerosis in Patients With PPMS
- Long-term Safety and Efficacy Evaluation of Ocrelizumab in Multiple Sclerosis Patients from Phase III Studies
- A Randomized, Double-Blind, Parallel-Group Study Comparing Remibrutinib and Teriflunomide in Relapsing Multiple Sclerosis Patients, with Open-Label Remibrutinib Extension
Data & Insights
Has run more than one trial at 236 of 424 partner sites.
Specializations
Multiple Sclerosis Research
This investigator specializes in conducting clinical research focused on relapsing multiple sclerosis (RMS) and progressive forms of multiple sclerosis. Their work encompasses various therapeutic approaches for treating different manifestations of MS.
- Relapsing Multiple Sclerosis Management
- Primary Progressive MS Treatment
- Secondary Progressive MS Interventions
Their research extends to evaluating novel therapeutic agents for managing MS progression and symptoms.
Therapeutic Innovation
The investigator's work involves assessment of various innovative treatment modalities including monoclonal antibodies and targeted therapies. Their research encompasses both established and experimental therapeutic approaches.
- BTK Inhibitor Therapeutics
- Monoclonal Antibody Treatments
- Novel Drug Delivery Systems
Their studies include evaluation of both intravenous and subcutaneous administration methods for MS treatments.
Clinical Assessment
The investigator focuses on long-term safety and efficacy evaluation of various MS treatments, utilizing advanced imaging and clinical assessment techniques.
- MRI-Based Disease Monitoring
- Disability Progression Assessment
- Safety Profile Evaluation
Their research methodology incorporates comprehensive monitoring of treatment outcomes in neurological conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.